Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vorinostat and Tamoxifen in Newly Diagnosed Breast Cancer
NCT01194427Phase 2Terminated
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center
- Start
- Mar 2011
- Primary completion
- Nov 2011
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vorinostat in breast cancer, sponsored by Sidney Kimmel Comprehensive Cancer Center. Started Mar 2011; status: terminated.
02
Drugs
vorinostat
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01194427.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01194427.